HbA1c Testing Market Research Report - Forecast till 2027

HbA1c Testing  Market: Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/7045-CR | October 2019 | Region: Global | 134 pages

HbA1c Testing Market Overview


HbA1c Testing Market is expected to register a CAGR of 12.24% to reach USD 1,992.44 Million by 2025. Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months.


HbA1c is a modified form of hemoglobin that is present in red blood cells. Most of the hemoglobin is in HbA form and during their lifespan, only a small fraction transforms into HbA1. HbA1 is further separated into HbA1a, HbA1b, and HbA1c. A high level of HbA1c is present in the body of diabetes patients as its formation occurs only during a process called glycosylation that converts glucose into glycogen for storage purposes. This HbA1c test results in the blood sugar level of the past 2 to 3 months of the diabetes patient’s body.


Worldwide, diabetes is one of the most prevalent epidemics and there are three types of diabetes. Out of them, type 2 diabetes is the common type. In September 2016, according to the National Center for Biotechnology Information (NCBI) research, diabetes is expected to be the seventh leading cause of death by the year 2030.  In 2017, according to the report of the International Diabetes Federation, there are 12,465,800 diabetes cases are reported globally and the prevalence of diabetes in Brazil was 8.7% among adults. Due to these increasing occurrences, various testing methods like HbA1c testing equipment are diagnosed to the patients. This is the major driving factor of the HbA1c testing market growth.


COVID-19 Analysis:


The COVID-19 pandemic affects millions of people and brought the world to a standstill. Diabetic people and the HbA1c testing market are also impacted by this pandemic. This testing volume was decreased by 66% in March and April 2020. Due to the pandemic, the stay at home orders and social distancing regulations are imposed and thus results in decrement of HbA1c testing volumes convert to postponed testing’s and decline in HbA1c testing frequency. Moreover, in this way or any other reasons, the missing of HbA1c point of care testing leads to adverse impacts of glucose control, clinical outcomes, and diabetes-related medical prices. In this way, the HbA1c testing procedures are impacted by COVID-19 and decline its market growth. Further, post-COVID, the HbA1c testing market is rapidly increased due to its increased usage.


Market Dynamics:


Drivers:


Rising per capita disposable income and developing healthcare infrastructure is the major driving factor for the growth of the market. Introducing advanced innovations in treatment options is propelling the growth of the market. Due to poor dietary choices, lack of physical activities, and higher stress levels, the people affected with diabetes are increasing day by day and the physicians are prescribing the HbA1c test fasting to their patients which increases the growth of the HbA1c testing market.


Additionally, the emergence of point of care and other latest innovations that reducing diabetes testing costs is aiding the HbA1c testing market growth. The continuous rise in the geriatric population leads to rising in diabetes patients all over the world. The rising scope of medical tourism in developing countries is boosting the HbA1c testing equipment market.


Restraint:


The testing devices are expensive. In few developing countries, these technologies are less adopted and are limiting the growth of the hemoglobin A1c testing devices market. 


Opportunities:


Rising adoption of advanced diagnostic tools and devices along with strategic activities like partnerships, and agreements among the prominent key players may create the opportunity to increase the market growth. The emergence of the latest testing procedures and advanced technologies like handheld devices is predicted to provide a lucrative opportunity for the HbA1c testing market growth. The rising awareness among the people regarding the management of diabetes efficiently is offering the growth of the market.


Challenges:


Manufacturing of these testing devices is cost high which poses a challenge for the market growth. Due to the discrepancies in interpretations, the HbA1c standard range testing result may be inaccurate which is hindering the HbA1c assay market growth.


Study Objectives -



  • To provide detailed information about the HbA1c testing market structure along with various forecast segments and sub-segments for the next 10 years.

  • To provide the factors that are affecting the growth of the HbA1c testing market value.

  • To analyze the HbA1c testing market industry analysis based on porter’s five force analysis, factors-price analysis, supply chain analysis, etc.

  • To provide history and forecast revenue segments and sub-segments of the HbA1c testing global market revenue for the main geographies.

  • To provide the country-level analysis of the current HbA1c testing market size and future prospective.

  • To provide country-level analysis of the HbA1c testing market industry growth by region, form, and application.

  • To provide a strategic profile of the prominent key players in the market, analyze their core competencies, and draw a global HbA1c testing market growth landscape.

  • To track and analyze new product developments, strategic alliances, and global HbA1c testing market research.


Segment Overview:


The global HbA1c testing market has been divided into segments based on technology, product, end-user, and region.


Based on Technology


Based on the technology, the global hemoglobin testing market is classified into few types as ion-exchange HPLC, TINIA, enzymatic assay, and others. Out of these, ion-exchange HPLC is holding the largest market share for its high demand in the market. It is the most widely used testing kit that consumes less time, recognizes variants, and is also used in point-of-care settings. TINIA is expected to grow at a significant rate during the review period which offers the benefits like accurate results, cost-effectiveness, and quick-swiftness.


Based on Product


The global HbA1c testing machine market based on the product is bifurcated into two types as reagents & kits, and instruments. Further, the instruments are divided into a bench-top device and a handheld device.


Based on End-user


By end-user, the global HbA1c testing equipment market is analyzed into hospitals &clinics, diagnostic laboratories, and others. The hospitals &clinics segment is dominating the HbA1c testing market share due to the growing geriatric population worldwide.


Based on Region


Regionally, the global Hemoglobin testing machine market is categorized into four main geographies such as Europe, Asia-Pacific, America, and the Middle East & Africa. America is dominating the largest market share for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in emerging countries like the US and Canada.


Regional Analysis -


Geographically, the HbA1c testing global market is divided into four major regions like Asia-Pacific, Europe, America, and the Middle East & Africa. Out of these regions, America is holding the leading position in the HbA1c testing market for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in the US and Canada. Europe is predicted to hold the second-largest market share for their increasing adoption of advanced diagnostic tools and devices coupled with strategic activities like partnerships and agreements by the major key players is accelerating the market growth in this region.


Due to the developing healthcare infrastructure and increasing per capita disposable income, Asia-Pacific is witnessing the fastest-growing region. Due to limited access to healthcare, growing awareness regarding healthcare, and availability of the latest treatments, the Middle East & Africa is witnessing steady growth.


Competitive Landscape


The prominent key players in the HbA1c testing market outlook are the following:



  • Bio-Rad Laboratories, Inc. (US)

  • Abbott Laboratories (US)

  • ARKRAY, Inc. (Japan)

  • Danaher Corporation (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Transasia Bio-Medicals (India)

  • Siemens Healthineers (US)

  • EKF Diagnostics (UK)

  • PTS Diagnostics (US)

  • Agappe Diagnostics Ltd (India)

  • Trinity Biotech PLC (Ireland)

  • DiaSys Diagnostic Systems GmbH (Germany)

  • CPC Diagnostics Pvt. Ltd. (India)

  • Tosoh India Pvt. Ltd (India)

  • Rapid Diagnostics Group of Companies (India)


Recent Developments




  • In January 2019, the most popular enterpriser EKF Diagnostics has introduced the world’s fastest hemoglobin analyzer DiaSpect Tm Hb in the US. It is used for the diagnosis of various disorders and increases the revenue of the company.




  • In December 2018, one of the top key players Siemens Healthineers announced the acquisition of Fast-Track Diagnostics (FTD) which is a global supplier of molecular diagnostic test kits. This acquisition improves patient experience and develops precision medicine.




  • In June 2017, the most famous vendor ARKRAY, Inc. decided to acquire HDK Philippines Inc. to establish ARKRAY Industry West, Inc. in the country that helps the company expansion for its operations in the Philippines.




Report Overview:


This HbA1c testing global market research includes the Market Overview, COVID-19 analysis, Market Dynamics, Study Objectives, Segment Overview, Regional Analysis, Competitive Landscape, Recent developments, Segmentation Table, and FAQs. The market scenario includes the HbA1c testing market drivers, restraints, challenges, and opportunities. The HbA1c Testing market forecast segments are technology, product, end-user, and region.


Segmentation Table


Globally, the HbA1c Testing market trends have been segmented into four types based on the technology, product, end-user, and region.


By Technology


Ion-exchange HPLC, TINIA, enzymatic assay, and others.


By Product


Reagents & kits, and instruments.


By End-user


Hospitals &clinics, diagnostic laboratories, and others.


By Region


Asia-Pacific, Europe, North America, and the rest of the world are the four main geographies included in the HbA1c testing market.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 1,992.44 Million
  CAGR   12.24% (2018-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Technology and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India)
  Key Market Opportunities   Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players
  Key Market Drivers

  • Developing healthcare infrastructure and increasing per capita disposable incomes
  • Availability of new advanced treatment options


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    HbA1c Testing Market is projected to grow at a 12.24% CAGR between 2016-2025.

    The Americas is expected to dominate the HbA1c Testing Market.

    HbA1c Testing Market is predicted to touch USD 1,992.44 million by 2025.

    The hospitals and clinics segment will lead the HbA1c Testing Market.

    The reagents & kits segment will dominate the HbA1c Testing Market.

    1 Executive Summary

    1.1 MARKET SYNOPSIS 14

    1.2 MARKET ATTRACTIVENESS ANALYSIS 15

    1.3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT 16

    1.4 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY 17

    1.5 GLOBAL HBA1C TESTING MARKET, BY END USER 18

    2 Market Introduction

    2.1 DEFINITION 19

    2.2 SCOPE OF THE STUDY 19

    2.3 RESEARCH OBJECTIVE 19

    2.4 MARKET STRUCTURE 20

    2.5 ASSUMPTIONS & LIMITATIONS 20

    3 Research Methodology

    3.1 DATA MINING 21

    3.2 SECONDARY RESEARCH 22

    3.3 PRIMARY RESEARCH 23

    3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24

    3.5 FORECASTING TECHNIQUES 25

    3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

    3.6.1 BOTTOM-UP APPROACH 27

    3.6.2 TOP-DOWN APPROACH 27

    3.7 DATA TRIANGULATION 28

    3.8 VALIDATION 28

    4 MARKET DYNAMICS

    4.1 OVERVIEW 29

    4.2 DRIVERS 30

    4.2.1 RISING PREVALENCE OF DIABETES 30

    4.2.2 INCREASING INITIATIVES BY KEY PLAYERS 30

    4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 30

    4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 30

    4.3 RESTRAINTS 32

    4.3.1 LIMITED INDICATIONS OF HBA1C TESTS 32

    4.3.2 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 32

    4.4 OPPORTUNITIES 33

    4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 33

    4.4.2 INCORPORATION OF VARIOUS TECHNOLOGIES IN HBA1C TESTING INSTRUMENTS 33

    5 MARKET FACTOR ANALYSIS

    5.1 PORTER’S FIVE FORCES MODEL 34

    5.1.1 THREAT OF NEW ENTRANTS 34

    5.1.2 BARGAINING POWER OF SUPPLIERS 35

    5.1.3 THREAT OF SUBSTITUTES 35

    5.1.4 BARGAINING POWER OF BUYERS 35

    5.1.5 INTENSITY OF RIVALRY 35

    5.2 VALUE CHAIN ANALYSIS 36

    5.2.1 R&D AND DESIGNING 37

    5.2.2 MANUFACTURING 37

    5.2.3 DISTRIBUTION 37

    5.2.4 MARKETING & SALES 37

    5.2.5 POST-SALES MONITORING 37

    6 HBA1C TESTING MARKET, BY PRODUCT

    6.1 OVERVIEW 38

    6.2 REAGENTS & KITS 39

    6.3 INSTRUMENTS 40

    6.3.1 BENCH-TOP DEVICE 41

    6.3.2 HANDHELD DEVICE 42

    7 HBA1C TESTING MARKET, BY TECHNOLOGY

    7.1 OVERVIEW 43

    7.2 ION-EXCHANGE HPLC 44

    7.3 ENZYMATIC ASSAY 45

    7.4 TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA) 46

    7.5 OTHERS 46

    8 HBA1C TESTING MARKET, BY END USER

    8.1 OVERVIEW 47

    8.2 HOSPITALS AND CLINICS 48

    8.3 DIAGNOSTIC LABORATORIES 49

    8.4 OTHERS 49

    9 GLOBAL HBA1C TESTING MARKET, BY REGION

    9.1 OVERVIEW 50

    9.2 AMERICAS 52

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.1 OVERVIEW 52

    9.2.2 NORTH AMERICA 55

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.2.1 US 58

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.2.2 CANADA 60

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.3 LATIN AMERICA 62

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3 EUROPE 64

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.1 OVERVIEW 64

    9.3.2 WESTERN EUROPE 67

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.1 UK 70

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.2 GERMANY 72

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.3 FRANCE 74

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.4 ITALY 76

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.5 SPAIN 78

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.6 REST OF WESTERN EUROPE 80

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.3 EASTERN EUROPE 82

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4 ASIA-PACIFIC 84

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.1 OVERVIEW 84

    9.4.2 CHINA 87

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.3 INDIA 89

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.4 JAPAN 91

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.5 SOUTH KOREA 93

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.6 AUSTRALIA 95

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.7 REST OF ASIA-PACIFIC 97

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5 MIDDLE EAST & AFRICA 99

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5.1 OVERVIEW 99

    9.5.2 MIDDLE EAST 102

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5.3 AFRICA 104

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    10 COMPETITIVE LANDSCAPE

    10.1 OVERVIEW 106

    10.2 COMPANY SHARE ANALYSIS, 2020 (%) 106

    11 COMPANY PROFILES

    11.1 ABBOTT LABORATORIES 108

    11.1.1 COMPANY OVERVIEW 108

    11.1.2 FINANCIAL OVERVIEW 108

    11.1.3 PRODUCTS/SERVICES OFFERED 109

    11.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

    11.1.5 SWOT ANALYSIS 109

    11.1.6 KEY STRATEGIES 110

    11.2 BIO-RAD LABORATORIES, INC. 111

    11.2.1 COMPANY OVERVIEW 111

    11.2.2 FINANCIAL OVERVIEW 111

    11.2.3 PRODUCTS/SERVICES OFFERED 112

    11.2.4 KEY DEVELOPMENTS 112

    11.2.5 SWOT ANALYSIS 113

    11.2.6 KEY STRATEGIES 113

    11.3 DANAHER CORPORATION 114

    11.3.1 COMPANY OVERVIEW 114

    11.3.2 FINANCIAL OVERVIEW 114

    11.3.3 PRODUCTS/SERVICES OFFERED 115

    11.3.4 KEY DEVELOPMENTS 115

    11.3.5 SWOT ANALYSIS 115

    11.3.6 KEY STRATEGIES 115

    11.4 F. HOFFMANN-LA ROCHE LTD 116

    11.4.1 COMPANY OVERVIEW 116

    11.4.2 FINANCIAL OVERVIEW 116

    11.4.3 PRODUCTS/SERVICES OFFERED 117

    11.4.4 KEY DEVELOPMENTS 117

    11.4.5 SWOT ANALYSIS 117

    11.4.6 KEY STRATEGIES 118

    11.5 SIEMENS HEALTHINEERS 119

    11.5.1 COMPANY OVERVIEW 119

    11.5.2 FINANCIAL OVERVIEW 119

    11.5.3 PRODUCTS/SERVICES OFFERED 120

    11.5.4 KEY DEVELOPMENTS 120

    11.5.5 SWOT ANALYSIS 120

    11.5.6 KEY STRATEGIES 121

    11.6 EKF DIAGNOSTICS 122

    11.6.1 COMPANY OVERVIEW 122

    11.6.2 FINANCIAL OVERVIEW 122

    11.6.3 PRODUCTS/SERVICES OFFERED 123

    11.6.4 KEY DEVELOPMENTS 123

    11.6.5 SWOT ANALYSIS 123

    11.6.6 KEY STRATEGIES 124


    11.7 ARKRAY, INC. 125

    11.7.1 COMPANY OVERVIEW 125

    11.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 125

    11.7.3 PRODUCTS/SERVICES OFFERED 125

    11.7.4 KEY DEVELOPMENTS 125

    11.7.5 SWOT ANALYSIS 126

    11.7.6 KEY STRATEGIES 126

    11.8 TRINITY BIOTECH PLC. 127

    11.8.1 COMPANY OVERVIEW 127

    11.8.2 FINANCIAL OVERVIEW 127

    11.8.3 PRODUCTS/SERVICES OFFERED 128

    11.8.4 KEY DEVELOPMENTS 128

    11.8.5 SWOT ANALYSIS 128

    11.8.6 KEY STRATEGIES 128

    11.9 PTS DIAGNOSTICS 129

    11.9.1 COMPANY OVERVIEW 129

    11.9.2 FINANCIAL OVERVIEW 129

    11.9.3 PRODUCTS/SERVICES OFFERED 129

    11.9.4 KEY DEVELOPMENTS 129

    11.9.5 SWOT ANALYSIS 130

    11.9.6 KEY STRATEGIES 130

    11.10 DIASYS DIAGNOSTIC SYSTEMS GMBH 131

    11.10.1 COMPANY OVERVIEW 131

    11.10.2 FINANCIAL OVERVIEW 131

    11.10.3 PRODUCTS/SERVICES OFFERED 131

    11.10.4 KEY DEVELOPMENTS 131

    11.10.5 SWOT ANALYSIS 132

    11.10.6 KEY STRATEGIES 132

    12 APPENDIX

    12.1 REFERENCES 133

    12.2 RELATED REPORTS 133

    13 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 20

    TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24

    TABLE 3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 39

    TABLE 4 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 40

    TABLE 5 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 40

    TABLE 6 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 41

    TABLE 7 GLOBAL HBA1C TESTING MARKET FOR BENCH-TOP DEVICE, BY REGION, 2020–2027 (USD MILLION) 41

    TABLE 8 GLOBAL HBA1C TESTING MARKET FOR HANDHELD DEVICE, BY REGION, 2020–2027 (USD MILLION) 42

    TABLE 9 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 44

    TABLE 10 GLOBAL HBA1C TESTING MARKET FOR ION-EXCHANGE HPLC, BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 11 GLOBAL HBA1C TESTING MARKET FOR ENZYMATIC ASSAY, BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 12 GLOBAL HBA1C TESTING MARKET FOR TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA), BY REGION,

    2020–2027 (USD MILLION) 46

    TABLE 13 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 48

    TABLE 14 GLOBAL HBA1C TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 48

    TABLE 15 GLOBAL HBA1C TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 49

    TABLE 16 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 51

    TABLE 17 AMERICAS: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 53

    TABLE 18 AMERICAS: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 53

    TABLE 19 AMERICAS: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 53

    TABLE 20 AMERICAS: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 54

    TABLE 21 AMERICAS: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 54

    TABLE 22 NORTH AMERICA: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55

    TABLE 23 NORTH AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 56

    TABLE 24 NORTH AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 56

    TABLE 25 NORTH AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57

    TABLE 26 NORTH AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 57

    TABLE 27 US: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 58

    TABLE 28 US: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 58

    TABLE 29 US: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59

    TABLE 30 US: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 59

    TABLE 31 CANADA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60

    TABLE 32 CANADA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 60

    TABLE 33 CANADA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 61

    TABLE 34 CANADA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 61

    TABLE 35 LATIN AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 62

    TABLE 36 LATIN AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 62

    TABLE 37 LATIN AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 63

    TABLE 38 LATIN AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 63

    TABLE 39 EUROPE: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 64

    TABLE 40 EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65

    TABLE 41 EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 65

    TABLE 42 EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 66

    TABLE 43 EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 66

    TABLE 44 WESTERN EUROPE: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67

    TABLE 45 WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68

    TABLE 46 WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 68

    TABLE 47 WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69

    TABLE 48 WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 69

    TABLE 49 UK: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70

    TABLE 50 UK: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 70

    TABLE 51 UK: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71

    TABLE 52 UK: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 71

    TABLE 53 GERMANY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72

    TABLE 54 GERMANY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 72

    TABLE 55 GERMANY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73

    TABLE 56 GERMANY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 73

    TABLE 57 FRANCE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74

    TABLE 58 FRANCE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 74

    TABLE 59 FRANCE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75

    TABLE 60 FRANCE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 75

    TABLE 61 ITALY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 76

    TABLE 62 ITALY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 76

    TABLE 63 ITALY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 77

    TABLE 64 ITALY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 77

    TABLE 65 SPAIN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78

    TABLE 66 SPAIN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 78

    TABLE 67 SPAIN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 79

    TABLE 68 SPAIN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 79

    TABLE 69 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

    TABLE 70 REST OF WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 80

    TABLE 71 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81

    TABLE 72 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 81

    TABLE 73 EASTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 82

    TABLE 74 EASTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 82

    TABLE 75 EASTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83

    TABLE 76 EASTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 83

    TABLE 77 ASIA-PACIFIC: HBA1C TESTING MARKET, BY COUNTRY,2020–2027 (USD MILLION) 84

    TABLE 78 ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

    TABLE 79 ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 85

    TABLE 80 ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

    TABLE 81 ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 86

    TABLE 82 CHINA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 87

    TABLE 83 CHINA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 87

    TABLE 84 CHINA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88

    TABLE 85 CHINA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 88

    TABLE 86 INDIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89

    TABLE 87 INDIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 89

    TABLE 88 INDIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90

    TABLE 89 INDIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 90

    TABLE 90 JAPAN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91

    TABLE 91 JAPAN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 91

    TABLE 92 JAPAN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92

    TABLE 93 JAPAN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 92

    TABLE 94 SOUTH KOREA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93

    TABLE 95 SOUTH KOREA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 93

    TABLE 96 SOUTH KOREA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94

    TABLE 97 SOUTH KOREA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 94

    TABLE 98 AUSTRALIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 95

    TABLE 99 AUSTRALIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 95

    TABLE 100 AUSTRALIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96

    TABLE 101 AUSTRALIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 96

    TABLE 102 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 97

    TABLE 103 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 97

    TABLE 104 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98

    TABLE 105 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 98

    TABLE 106 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY REGION,2020–2027 (USD MILLION) 99

    TABLE 107 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100

    TABLE 108 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 100

    TABLE 109 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101

    TABLE 110 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 101

    TABLE 111 MIDDLE EAST: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102

    TABLE 112 MIDDLE EAST: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 102

    TABLE 113 MIDDLE EAST: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 103

    TABLE 114 MIDDLE EAST: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 103

    TABLE 115 AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

    TABLE 116 AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 104

    TABLE 117 AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105

    TABLE 118 AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 105

    TABLE 119 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 109

    TABLE 120 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

    TABLE 121 BIO-RAD LABORATORIES INC.: PRODUCTS/SERVICES OFFERED 112

    TABLE 122 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 112

    TABLE 123 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 115

    TABLE 124 DANAHER CORPORATION: KEY DEVELOPMENTS 115

    TABLE 125 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 117

    TABLE 126 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 117

    TABLE 127 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 120

    TABLE 128 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 120

    TABLE 129 EKF DIAGNOSTICS PRODUCTS/SERVICES OFFERED 123

    TABLE 130 EKF DIAGNOSTICS KEY DEVELOPMENTS 123

    TABLE 131 ARKRAY, INC.: PRODUCTS/SERVICES OFFERED 125

    TABLE 132 ARKRAY, INC.: KEY DEVELOPMENTS 125

    TABLE 133 TRINITY BIOTECH PLC.: PRODUCTS/SERVICES OFFERED 128

    TABLE 134 PTS DIAGNOSTICS: PRODUCTS/SERVICES OFFERED 129

    TABLE 135 DIASYS DIAGNOSTIC SYSTEMS GMBH: PRODUCTS/SERVICES OFFERED 131

    14 List of Figures

    FIGURE 1 MARKET SYNOPSIS 14

    FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2020) 15

    FIGURE 3 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY PRODUCT 16

    FIGURE 4 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY TECHNOLOGY 17

    FIGURE 5 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY END USER 18

    FIGURE 6 GLOBAL HBA1C TESTING MARKET: STRUCTURE 20

    FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 26

    FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 29

    FIGURE 9 DRIVERS IMPACT ANALYSIS 31

    FIGURE 10 RESTRAINT IMPACT ANALYSIS 32

    FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HBA1C TESTING MARKET 34

    FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 36

    FIGURE 13 GLOBAL HBA1C TESTING MARKET SHARE, BY PRODUCT, 2020 (%) 38

    FIGURE 14 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 38

    FIGURE 15 GLOBAL HBA1C TESTING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 43

    FIGURE 16 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 43

    FIGURE 17 GLOBAL HBA1C TESTING MARKET SHARE, BY END USER, 2020 (%) 47

    FIGURE 18 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020 & 2027 (USD MILLION) 47

    FIGURE 19 GLOBAL HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 50

    FIGURE 20 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 50

    FIGURE 21 AMERICAS: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 52

    FIGURE 22 NORTH AMERICA: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 55

    FIGURE 23 EUROPE: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 64

    FIGURE 24 WESTERN EUROPE: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 67

    FIGURE 25 ASIA-PACIFIC: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 84

    FIGURE 26 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 99

    FIGURE 27 GLOBAL HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 106

    FIGURE 28 INDIA HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 107

    FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 108

    FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS 109

    FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 111

    FIGURE 32 BIO-RAD LABORATORIES INC: SWOT ANALYSIS 113

    FIGURE 33 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114

    FIGURE 34 DANAHER CORPORATION: SWOT ANALYSIS 115

    FIGURE 35 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 116

    FIGURE 36 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 117

    FIGURE 37 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 119

    FIGURE 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 120

    FIGURE 39 EKF DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT 122

    FIGURE 40 EKF DIAGNOSTICS: SWOT ANALYSIS 123

    FIGURE 41 ARKRAY, INC.: SWOT ANALYSIS 126

    FIGURE 42 TRINITY BIOTECH PLC.: FINANCIAL OVERVIEW SNAPSHOT 127

    FIGURE 43 TRINITY BIOTECH PLC.: SWOT ANALYSIS 128

    FIGURE 44 PTS DIAGNOSTICS: SWOT ANALYSIS 130

    FIGURE 45 DIASYS DIAGNOSTIC SYSTEMS GMBH: SWOT ANALYSIS 132



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.